BioMedical Technology Solutions Holdings, Inc. (OTC BB: BMTL) CEO Interview

This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.

Special deals for our readers
Are you qualified for the Visa Black Card?
The World’s Most Prestigious and Versatile Credit Card. Apply Now!

Be a more profitable investor:
What’s Jim Cramer trading in his personal portfolio? Click here

Get an Equifax 3-in-1 Credit Report Now!

Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing.
Find out why TradeKing.com was ranked #1 Discount Broker by SmartMoney Magazine two years running! (August 2006 & 2007).

Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition!

LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount.

Get FICO Score Watch Now!

Free Quicken Online automatically categorizes your expenses.

Click here to get access to powerful investing tools only available at Investor’s Business Daily.

Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here

bmts_logo

OTC BB: BMTL
BioMedical Technology Solutions
Interview with:
Donald Cox
CEO, Chair, Pres.

Website
Company Info
BioMedical Technology Solutions Holdings, Inc. formerly CET Services, Inc. (CET), is a provider of safe and environmentally sound medical waste disposal equipment for needles and red bag waste, commonly found in medical, dental, veterinary, nursing, assisted living and other health care facilities. The product, known as the Demolizer, allows the medical staff to safely and inexpensively account for medical waste. The Demolizer’s patented treatment process uses dry heat technology, rendering waste 99.9% sterile, and needles unrecognizable. The treated waste is then properly labeled and simply thrown away as common trash. In August 2008, the Company completed its acquisition of BioMedical Technology Solutions, Inc.

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.